A respiratory product company is expanding into the sleep therapy market with a portfolio of full face, nasal cushion, and nasal pillow masks for obstructive sleep apnea.
Key takeaways:
- Inogen has launched its Aurora CPAP masks in the United States, marking its entry into the obstructive sleep apnea market.
- The portfolio includes the F1 Full Face, N1 Nasal Cushion, and P1 Nasal Pillows, designed to fit diverse patient needs.
- The company aims to leverage its existing home respiratory distribution channels and partnerships to bring the masks to providers.
- A 30-day patient-use study involving 140 patients found that a majority reported being highly satisfied with the masks.
Home respiratory company Inogen Inc has launched Aurora CPAP masks, a new product line for patients with obstructive sleep apnea (OSA), marking the company’s strategic entry into the sleep therapy market.
“The launch of Aurora CPAP masks represents a pivotal step in Inogen’s evolution towards expanding into a broad home care respiratory solutions company and our entry into the sleep apnea market,” says Kevin Smith, president and CEO, in a release. “With Aurora Masks, we are bringing the same patient-centric innovation that defines our respiratory solutions to a new category, delivering comfort, performance, and reliability. We see Aurora Masks as a growth catalyst that reinforces our commitment to leading in patient outcomes in home respiratory care.”
The Aurora Mask portfolio—which includes the F1 Full Face, N1 Nasal Cushion, and P1 Nasal Pillows—is designed to meet the diverse needs of most patients using CPAP devices.
Inogen Aurora Mask Line Key Features
- Headgearfeatures a triple-material design with ultrasonic edge sealing technology
- Medical-grade rebound silicone cushion is soft, airtight, and hypoallergenic
- A honeycomb vent design promotes a peaceful sleep environment for users and partners
- Easy to assemble, disassemble, and clean for everyday convenience
- Works seamlessly with most CPAP devices
According to the company, the launch is supported by a patient-use study in which the majority of 140 patients reported high satisfaction with the Aurora masks. The 30-day study involved patients who had been on CPAP therapy for at least six months with usage of at least five nights per week.
